Croda Debt to Equity Ratio 2019-2024 | COIHY
Current and historical debt to equity ratio values for Croda (COIHY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Croda debt/equity for the three months ending June 30, 2024 was 0.26.
| Croda Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-06-30 |
$1.57B |
$2.95B |
0.53 |
| 2023-12-31 |
$1.51B |
$2.95B |
0.51 |
| 2023-06-30 |
$1.52B |
$2.91B |
0.52 |
| 2022-12-31 |
$1.46B |
$3.01B |
0.49 |
| 2021-12-31 |
$2.10B |
$2.42B |
0.87 |
| 2021-06-30 |
$2.16B |
$2.33B |
0.93 |
| 2020-12-31 |
$1.84B |
$2.05B |
0.90 |
| 2020-06-30 |
$1.28B |
$1.22B |
1.05 |
| 2019-12-31 |
$1.31B |
$1.11B |
1.18 |
| 2019-06-30 |
$1.40B |
$1.12B |
1.25 |
| 2018-12-31 |
$1.22B |
$1.33B |
0.92 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$0.000B |
$2.107B |
|
Croda International plc engages in the manufacture and distribution of specialty chemicals. Its operating segment consists of Personal Care, Life Sciences, Performance Technologies and Industrial Chemicals. Personal Care segment offers ingredients for the personal care industry such as skin care, sun care, hair care, colour cosmetics and toiletries. Life Sciences segment comprises the health care business, which delivers ingredients and formulation expertise to pharmaceutical and nutritional markets and the crop care business which provides ingredients and formulation expertise to agrochemical companies. Performance Technologies segment includes lubricants, coatings and polymers, geo technologies, polymer additives and home care. Industrial Chemicals segment provides bio-based phase change material for thermal management, dispersants and additives for catalysts, electronics and advance ceramics. Croda International plc is headquartered in Goole, the United Kingdom.
|
